CDC. Antibiotic Resistance Threats in the United States, 2019 (U.S. Department of Health and Human Services, CDC 2019); https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
Louie, T. J. et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N. Engl. J. Med. 364, 422–431 (2011).
Crawford, T., Huesgen, E. & Danziger, L. Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection. Am. J. Health Syst. Pharm. 69, 933–943 (2012).
Louie, T. J., Emery, J., Krulicki, W., Byrne, B. & Mah, M. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection. Antimicrob. Agents Chemother. 53, 261–263 (2009).
Lee, Y. J. et al. Protective factors in the intestinal microbiome against Clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation. J. Infect. Dis. 215, 1117–1123 (2017).
Vincent, C. & Manges, A. R. Antimicrobial use, human gut microbiota and Clostridium difficile colonization and infection. Antibiotics 4, 230–253 (2015).
Boyaci, H. et al. Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts. eLife 7, e34823 (2018).
Lin, W. et al. Structural basis of transcription inhibition by fidaxomicin (lipiarmycin A3). Mol. Cell 70, 60–71.e15 (2018).
Morichaud, Z., Chaloin, L. & Brodolin, K. Regions 1.2 and 3.2 of the RNA polymerase σ subunit promote DNA melting and attenuate action of the antibiotic lipiarmycin. J. Mol. Biol. 428, 463–476 (2016).
Tupin, A., Gualtieri, M., Leonetti, J. P. & Brodolin, K. The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site. EMBO J. 29, 2527–2537 (2010).
Boyaci, H., Chen, J., Jansen, R., Darst, S. A. & Campbell, E. A. Structures of an RNA polymerase promoter melting intermediate elucidate DNA unwinding. Nature 565, 382–385 (2019).
Chen, J., Boyaci, H. & Campbell, E. A. Diverse and unified mechanisms of transcription initiation in bacteria. Nat. Rev. Microbiol. 19, 95–109 (2021).
Lane, W. J. & Darst, S. A. Molecular evolution of multisubunit RNA polymerases: sequence analysis. J. Mol. Biol. 395, 671–685 (2010).
Mani, N., Dupuy, B. & Sonenshein, A. L. Isolation of RNA polymerase from Clostridium difficile and characterization of glutamate dehydrogenase and rRNA gene promoters in vitro and in vivo. J. Bacteriol. 188, 96–102 (2006).
Cardone, G., Heymann, J. B. & Steven, A. C. One number does not fit all: mapping local variations in resolution in cryo-EM reconstructions. J. Struct. Biol. 184, 226–236 (2013).
Bae, B. et al. Phage T7 Gp2 inhibition of Escherichia coli RNA polymerase involves misappropriation of σ70 domain 1.1. Proc. Natl Acad. Sci. USA 110, 19772–19777 (2013).
Pei, H. H. et al. The δ subunit and NTPase HelD institute a two-pronged mechanism for RNA polymerase recycling. Nat. Commun. 11, 6418 (2020).
Fang, C. et al. The bacterial multidrug resistance regulator BmrR distorts promoter DNA to activate transcription. Nat. Commun. 11, 6284 (2020).
Campbell, E. A. et al. Structure of the bacterial RNA polymerase promoter specificity σ subunit. Mol. Cell 9, 527–539 (2002).
Hubin, E. A. et al. Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA. eLife 6, e22520 (2017).
Chen, J. et al. 6S RNA mimics B-form DNA to regulate Escherichia coli RNA polymerase. Mol. Cell 68, 388–397.e386 (2017).
Feklistov, A. et al. RNA polymerase motions during promoter melting. Science 356, 863–866 (2017).
Babakhani, F., Seddon, J. & Sears, P. Comparative microbiological studies of transcription inhibitors fidaxomicin and the rifamycins in Clostridium difficile. Antimicrob. Agents Chemother. 58, 2934–2937 (2014).
Kuehne, S. A. et al. Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin. J. Antimicrob. Chemother. 73, 973–980 (2018).
Goldstein, E. J., Babakhani, F. & Citron, D. M. Antimicrobial activities of fidaxomicin. Clin. Infect. Dis. 55, S143–S148 (2012).
Kurabachew, M. et al. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 62, 713–719 (2008).
Srivastava, A. et al. New target for inhibition of bacterial RNA polymerase: ‘switch region’. Curr. Opin. Microbiol. 14, 532–543 (2011).
Forster, S. C. et al. A human gut bacterial genome and culture collection for improved metagenomic analyses. Nat. Biotechnol. 37, 186–192 (2019).
Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
Wexler, A. G. & Goodman, A. L. An insider’s perspective: Bacteroides as a window into the microbiome. Nat. Microbiol 2, 17026 (2017).
King, C. H. et al. Baseline human gut microbiota profile in healthy people and standard reporting template. PLoS ONE 14, e0206484 (2019).
Corbett, D. et al. Potentiation of antibiotic activity by a novel cationic peptide: potency and spectrum of activity of SPR741. Antimicrob. Agents Chemother. 61, e00200–17 (2017).
Vaara, M. et al. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Antimicrob. Agents Chemother. 54, 3341–3346 (2010).
Welch, M. et al. Design parameters to control synthetic gene expression in Escherichia coli. PLoS ONE 4, e7002 (2009).
Salis, H. M., Mirsky, E. A. & Voigt, C. A. Automated design of synthetic ribosome binding sites to control protein expression. Nat. Biotechnol. 27, 946–950 (2009).
Czyz, A., Mooney, R. A., Iaconi, A. & Landick, R. Mycobacterial RNA polymerase requires a U-tract at intrinsic terminators and is aided by NusG at suboptimal terminators. Mbio 5, e00931 (2014).
Yang, X. & Lewis, P. J. Overproduction and purification of recombinant Bacillus subtilis RNA polymerase. Protein Expr. Purif. 59, 86–93 (2008).
Davis, E., Chen, J., Leon, K., Darst, S. A. & Campbell, E. A. Mycobacterial RNA polymerase forms unstable open promoter complexes that are stabilized by CarD. Nucleic Acids Res. 43, 433–445 (2015).
Morin, A. et al. Collaboration gets the most out of software. eLife 2, e01456 (2013).
Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41–60 (2005).
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
Heymann, J. B. & Belnap, D. M. Bsoft: image processing and molecular modeling for electron microscopy. J. Struct. Biol. 157, 3–18 (2007).
Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296–W303 (2018).
Guo, X. et al. Structural basis for NusA stabilized transcriptional pausing. Mol. Cell 69, 816–827.e814 (2018).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Afonine, P. V. et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. D 74, 814–840 (2018).
Toulokhonov, I., Zhang, J., Palangat, M. & Landick, R. A central role of the RNA polymerase trigger loop in active-site rearrangement during transcriptional pausing. Mol. Cell 27, 406–419 (2007).
Weilbaecher, R., Hebron, C., Feng, G. & Landick, R. Termination-altering amino acid substitutions in the β′ subunit of Escherichia coli RNA polymerase identify regions involved in RNA chain elongation. Genes Dev. 8, 2913–2927 (1994).
Burby, P. E. & Simmons, L. A. CRISPR/Cas9 editing of the Bacillus subtilis genome. Bio. Protoc. 7, e2272 (2017).
Hockett, K. L. & Baltrus, D. A. Use of the soft-agar overlay technique to screen for bacterially produced inhibitory compounds. J. Vis. Exp. 119, 55064 (2017).
Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127–134 (1995).
Stamatakis, A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22, 2688–2690 (2006).
Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucl. Acids Res. 47 (W1), W256–W259 (2019).
More News
Plastic pollution: three numbers that support a crackdown
Probing entanglement in a 2D hard-core Bose–Hubbard lattice – Nature
High carrier mobility along the [111] orientation in Cu2O photoelectrodes – Nature